ImmunityBio (IBRX) Stock Price, Quote, News & History | Benzinga

ImmunityBio Inc (IBRX) Stock Price, Quote, News & History

IBRXNASDAQ

Trade with Public

Trade with Public

$7.88

At close: Jul 15, 5:00 PM EST

$7.95

0.070.89%

After Hours: 7:58 PM EST

OverviewNews Earnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 13.55M

Day Range

- - -

52 Wk Range

1.95 - 12.43

Market Cap

$8.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

33.94%

Days to Cover

8.66

Recent Immunitybio Inc News

Squeeze Watch: 10 Stocks Bears Love to Hate Most Right Now

Lucid, Figma, SoundHound and Ondas are among the most heavily shorted stocks in the market right now.

Erica Kollmann

Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'

Jim Cramer recommended buying CAVA Group (CAVA), citing its potential and tasty, clean, and fun concept, also likes Trulieve Cannabis (TRLV) and advised holding onto Ashland (ASH).

Avi Kapoor

TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday

TAT Technologies Ltd (TATT) reported better-than-expected Q1 results, sending shares up 11.7%. Other big gainers include IMVT, SLS, TE, VUZI, ROIV, POET, ARM, AMC, ALAB, DSGN, and TLN.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-294.39M

Investing Cash Flow (TTM)

-185.58M

Financing Cash Flow (TTM)

625.15M

Free Cash Flow (TTM)

-299.31M

Capital Expenditure (TTM)

-4.92M

Net Change in Cash (TTM)

145.18M

Analyst Trends and Forecast

6

Mar

2

Apr

3

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.59B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

53.81

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-10.79%

Earnings Yield % (FWD)

-10.29%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.83

Company Debt

Total Debt

$678.39M

LT Debt

$678.39M

LT Debt Issuance (TTM)

$61.00K

LT Debt Repayment (TTM)

-$41.00K

Total Cash

$205.19M

Debt to Equity

-

Issuance of Debt (TTM)

$20.00K

Repayment of Debt (TTM)

-$41.00K

Key Statistics

Open

-

Close

-

Volume / Avg.

0 / 13.55M

Day Range

- - -

52 Wk Range

1.95 - 12.43

Market Cap

$8.33B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

49

Short Interest

33.94%

Days to Cover

8.66

About

Sector

Health Care

Industry

Biotechnology

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy ImmunityBio (IBRX) stock?

A

You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ImmunityBio (IBRX) competitors?

A

There are no as such competitors for ImmunityBio.

Q

What is the forecast, or price target, for ImmunityBio (IBRX) stock?

A

ImmunityBio has a consensus price target of $14.63.

Q

What is the current price for ImmunityBio (IBRX)?

A

The stock price for ImmunityBio (NASDAQ: IBRX) is $7.95 last updated July 14, 2026 at 7:58 PM EDT.

Q

Does ImmunityBio (IBRX) pay a dividend?

A

There are no upcoming dividends for ImmunityBio.

Q

When is ImmunityBio (NASDAQ:IBRX) reporting earnings?

A

ImmunityBio does not have any upcoming earnings scheduled.

Q

Is ImmunityBio (IBRX) going to split?

A

There is no upcoming split for ImmunityBio.

Q

What sector and industry does ImmunityBio (IBRX) operate in?

A

ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.